Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Moderate Psoriasis”

Showing 20 of 0 results

Large-scale testing (Phase 3)Looking for participantsNCT07326813
What this trial is testing

A Clinical Study to Evaluate the Efficacy and Safety of D-2570 in the Treatment of Moderate to Severe Plaque Psoriasis

Who this might be right for
Plaque Psoriasis
InventisBio Co., Ltd 477
Large-scale testing (Phase 3)Ended earlyNCT04305327
What this trial is testing

Efficacy and Safety of Brodalumab in Adolescents From 12 to 17 Years of Age With Moderate-to-severe Plaque Psoriasis

Who this might be right for
Psoriasis
LEO Pharma 12
Post-approval studies (Phase 4)Study completedNCT02125279
What this trial is testing

Long Term Safety and Efficacy Study of Calcitriol 3 mcg/g Ointment in Pediatric Subjects With Plaque Psoriasis

Who this might be right for
Psoriasis Vulgaris
Galderma R&D 54
Testing effectiveness (Phase 2)Study completedNCT00134394
What this trial is testing

Etanercept With Tacrolimus for Psoriasis

Who this might be right for
Psoriasis
University of Medicine and Dentistry of New Jersey 20
Very early researchStudy completedNCT04410237
What this trial is testing

Triamcinolone Acetonide Injections in Mild-to-moderate Chronic Plaque Psoriasis With a Novel Needle-free Drug-delivery System

Who this might be right for
Psoriasis
University Hospitals Cleveland Medical Center 13
Large-scale testing (Phase 3)Study completedNCT02325219
What this trial is testing

An Efficacy and Safety of CNTO 1959 (Guselkumab) in Participants With Moderate to Severe Plaque-type Psoriasis

Who this might be right for
Psoriasis
Janssen Pharmaceutical K.K. 192
Large-scale testing (Phase 3)Study completedNCT01235442
What this trial is testing

Evaluate Efficacy, and Safety of Topical Therapy and Etanercept in Subjects With Moderate to Severe Plaque Psoriasis

Who this might be right for
Psoriasis
Amgen 592
Not applicableEnded earlyNCT00184366
What this trial is testing

Classification and Characterization of Patients Treated With Efalizumab for Plaque Psoriasis

Who this might be right for
Plaque Psoriasis
Norwegian University of Science and Technology 96
Early research (Phase 1)Study completedNCT06738277
What this trial is testing

This is Comparative Study in Normal Healthy Subjects to Evaluate Pharmacokinetics, Safety, Tolerability of Bmab 1200 -Autoinjector (AI) After Single Subcutaneous Injection (45 mg) in Comparison With Bmab 1200 -Prefilled Syringe (PFS).

Who this might be right for
Moderate to Severe Chronic Plaque Psoriasis
Biocon Biologics UK Ltd 186
Post-approval studies (Phase 4)Study completedNCT03587194
What this trial is testing

Evaluation of Add on Enstilar in Patients Using Otezla for Psoriasis

Who this might be right for
Psoriasis
Psoriasis Treatment Center of Central New Jersey 50
Large-scale testing (Phase 3)Ended earlyNCT03556202
What this trial is testing

A Long-term Study to Evaluate Safety and Maintenance of Treatment Effect of LY3074828 in Participants With Moderate-to-Severe Plaque Psoriasis (OASIS-3)

Who this might be right for
Psoriasis
Eli Lilly and Company 1,936
Testing effectiveness (Phase 2)Study completedNCT06073119
What this trial is testing

Evaluate Efficacy and Safety of SAR441566 in Adults With Plaque Psoriasis

Who this might be right for
Psoriasis
Sanofi 221
Large-scale testing (Phase 3)Study completedNCT03047395
What this trial is testing

Assess the Safety and Efficacy of Risankizumab for Maintenance in Moderate to Severe Plaque Type Psoriasis ( LIMMITLESS )

Who this might be right for
Psoriasis
AbbVie 2,170
Large-scale testing (Phase 3)Study completedNCT04435600
What this trial is testing

Subcutaneous Risankizumab Injection for Pediatric Participants With Moderate to Severe Plaque Psoriasis to Assess Change in Disease Symptoms

Who this might be right for
Psoriasis
AbbVie 139
Large-scale testing (Phase 3)Study completedNCT02684357
What this trial is testing

BI 655066 Versus Placebo & Active Comparator (Ustekinumab) in Patients With Moderate to Severe Chronic Plaque Psoriasis

Who this might be right for
Psoriasis
AbbVie 577
Large-scale testing (Phase 3)Study completedNCT01177800
What this trial is testing

Evaluate Safety and Efficacy of Infliximab in Chinese Participants With Moderate to Severe Plaque-type Psoriasis

Who this might be right for
Psoriasis
Xian-Janssen Pharmaceutical Ltd. 129
Post-approval studies (Phase 4)Study completedNCT05969223
What this trial is testing

Study to Assess the Safety and Efficacy of Subcutaneously Injected Risankizumab in Adult Participants With Genital or Scalp Psoriasis

Who this might be right for
Genital PsoriasisScalp Psoriasis
AbbVie 214
Testing effectiveness (Phase 2)Study completedNCT00941031
What this trial is testing

AIN457 Regimen Finding Study in Patients With Moderate to Severe Psoriasis

Who this might be right for
Chronic Plaque-type Psoriasis
Novartis Pharmaceuticals 404
Post-approval studies (Phase 4)UnknownNCT03408756
What this trial is testing

Comparison of Oral Versus Subcutaneous Route of Methotrexate Administration in Moderate to Severe Psoriasis

Who this might be right for
Psoriasis Vulgaris
Post Graduate Institute of Medical Education and Research, Chandigarh 100
Testing effectiveness (Phase 2)Study completedNCT01483924
What this trial is testing

Study to Evaluate Apo805K1 in Subjects With Moderate to Severe Chronic Plaque Psoriasis

Who this might be right for
Plaque Psoriasis
ApoPharma 60
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation